We’re excited to announce that Abterra Bio has been chosen as the Winner of the 19th Seattle Angel Conference and the Audience Favorite Award.

This year, there were 81 start-up companies from all over the US that had applied. The selection process took around 2-3 months and consisted of 3 phases.

Phase 1: Founders and investors went through a few workshops that addressed the basic issues around Angel Investing.

Phase 2: Investors selected 24 companies that they wanted to explore based on the company profiles. Next, 12 Semi-Finalists were selected after 3-minute pitches and a little bit of Q&A. Then, 6 Finalists were chosen after 10-minute pitches.

Phase 3: Investors were divided into teams to do due diligence of these 6 companies. They explored the Team, the financial discipline, and the market engagement of each company. At the end of this process, investors decided on which company to invest the fund that was raised.

We are honored to be chosen from an amazing group of finalists. We would like to thank the investors for believing in what we do.

Learn more about the finalists.